Ansar A Pathan - JoVE Visualize

Showing results (21-30 of 38) with videos related to

Pageof 4

Sort By:

Vaccine|July 14, 2012

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adultsAnsar A Pathan, Angela M Minassian, Clare R Sander, et al.

Immunobiology|April 8, 2019

Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivityAhmed A Al-Qahtani, Valarmathy Murugaiah, Hani A Bashir, et al.

Frontiers in Immunology|May 3, 2024

Mapping the interaction sites of human and avian influenza A viruses and complement factor HIman Rabeeah, Elizabeth Billington, Béatrice Nal, et al.

AIDS (London, England)|November 21, 2002

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cellsAnn L N Chapman, Mwansa Munkanta, Katalin A Wilkinson, et al.

Plos One|October 25, 2007

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnsar A Pathan, Clare R Sander, Helen A Fletcher, et al.

Frontiers in Immunology|August 15, 2018

Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein DMohammed N Al-Ahdal, Valarmathy Murugaiah, Praveen M Varghese, et al.

Vaccine|August 7, 2008

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, et al.

Journal of Biomedical Nanotechnology|June 16, 2016

Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T CellsKirsten M Pondman, Anthony G Tsolaki, Basudev Paudyal, et al.

Vaccine|September 10, 2005

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.

Immunobiology|September 15, 2019

Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patientsSyreeta DeCordova, Amr Abdelgany, Valarmathy Murugaiah, et al.

Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:

Pageof 4

Vaccine|July 14, 2012

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adultsAnsar A Pathan, Angela M Minassian, Clare R Sander, et al.

Immunobiology|April 8, 2019

Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivityAhmed A Al-Qahtani, Valarmathy Murugaiah, Hani A Bashir, et al.

Frontiers in Immunology|May 3, 2024

Mapping the interaction sites of human and avian influenza A viruses and complement factor HIman Rabeeah, Elizabeth Billington, Béatrice Nal, et al.

AIDS (London, England)|November 21, 2002

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cellsAnn L N Chapman, Mwansa Munkanta, Katalin A Wilkinson, et al.

Plos One|October 25, 2007

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnsar A Pathan, Clare R Sander, Helen A Fletcher, et al.

Frontiers in Immunology|August 15, 2018

Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein DMohammed N Al-Ahdal, Valarmathy Murugaiah, Praveen M Varghese, et al.

Vaccine|August 7, 2008

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, et al.

Journal of Biomedical Nanotechnology|June 16, 2016

Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T CellsKirsten M Pondman, Anthony G Tsolaki, Basudev Paudyal, et al.

Vaccine|September 10, 2005

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.

Immunobiology|September 15, 2019

Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patientsSyreeta DeCordova, Amr Abdelgany, Valarmathy Murugaiah, et al.

Pageof 4